Literature DB >> 11567758

A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model.

B Zheng1, P C Woo, M Ng, H Tsoi, L Wong, K Yuen.   

Abstract

In the previous study, we had shown that live oral vaccination with Salmonella typhimurium delivering plasmid DNA-HBsAg (oral DNA vaccine) evoked a vigorous T cell response and a weak antibody response with predominant subclass IgG2a in mice, suggesting a significant involvement by professional antigen presenting cells (APC). In the present study, this possibility was further studied by infecting peritoneal macrophages (MPhi) with the oral DNA vaccine. Although, the infected cells could only express low level of the viral antigen, they nevertheless stimulated a vigorous lymphocyte proliferation of splenocytes from immune mice, induced these cells to elaborate interferon-gamma and stimulated development of HBV-specific cytotoxicity against target cells expressing the viral antigen. Infusion of the infected MPhi evoked a vigorous Th 1 and cytotoxic T lymphocyte (CTL) response and a weak IgG2a antibody response in mice, which was essentially the same as response to the oral DNA vaccine. In contrast, recombinant protein vaccine evoked a vigorous IgG1 antibody response and a weak T cell response. While, given intramuscularly, the same plasmid DNA vaccine as that contained in the oral DNA vaccine evoked a vigorous IgG1 antibody response and a moderate T cell response in these animals. It was concluded that professional APC may orchestrate the immune response to live oral DNA vaccine and it was of interest to note that different vaccine formulation and routes of administration evoke distinct immune response to HBV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567758     DOI: 10.1016/s0264-410x(01)00272-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Progress towards a needle-free hepatitis B vaccine.

Authors:  Filipa Lebre; Gerrit Borchard; Maria Conceição Pedroso de Lima; Olga Borges
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

2.  Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.

Authors:  Hui Hu; Xinya Lu; Ling Tao; Bingke Bai; Zhenfeng Zhang; Yao Chen; Fangliang Zheng; Jianjun Chen; Ze Chen; Hanzhong Wang
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

3.  Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier.

Authors:  Chang-Cun Guo; Jie Ding; Bo-Rong Pan; Zhao-Cai Yu; Quan-Li Han; Fan-Ping Meng; Na Liu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

4.  SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.

Authors:  Patrick C Y Woo; Susanna K P Lau; Hoi-Wah Tsoi; Zhi-Wei Chen; Beatrice H L Wong; Linqi Zhang; Jim K H Chan; Lei-Po Wong; Wei He; Chi Ma; Kwok-Hung Chan; David D Ho; Kwok-Yung Yuen
Journal:  Vaccine       Date:  2005-10-10       Impact factor: 3.641

Review 5.  Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.

Authors:  Nyasha Chin'ombe
Journal:  Viruses       Date:  2013-08-28       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.